NUCAMMA RX— 510(k) K982045

Substantially Equivalent

Is2 Research, Inc.

FDA 510(k) clearance K982045 for NUCAMMA RX, Substantially Equivalent on 1998-09-02. Applicant: Is2 Research, Inc..

Clearance details

Applicant: Is2 Research, Inc.
Product code: Code KPS
Advisory panel: Radiology
Date received: 1998-06-10
Decision date: 1998-09-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Nepean, Ontario, CA

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.